Public Employees Retirement System of Ohio Sells 1,403 Shares of Waters Corporation $WAT

Posted by Brenda Bartman on Sep 1st, 2026

Public Employees Retirement System of Ohio decreased its position in shares of Waters Corporation (NYSE:WAT – Free Report) by 4.8% in the 2nd quarter, HoldingsChannel reports. The fund owned 28,021 shares of the medical instruments supplier’s stock after selling 1,403 shares during the period. Public Employees Retirement System of Ohio’s holdings in Waters were worth $10,509,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of WAT. Zions Bancorporation National Association UT lifted its holdings in shares of Waters by 121.2% in the 4th quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 40 shares in the last quarter. PenderFund Capital Management Ltd. acquired a new stake in Waters in the 2nd quarter valued at $28,000. First Bancorp Inc ME bought a new stake in Waters during the 2nd quarter valued at $30,000. SHP Wealth Management bought a new stake in Waters during the 4th quarter valued at $32,000. Finally, DV Equities LLC acquired a new position in Waters during the fourth quarter worth $32,000. Institutional investors own 94.01% of the company’s stock.

Waters Price Performance

Shares of NYSE:WAT opened at $414.94 on Tuesday. The company has a market capitalization of $40.77 billion, a P/E ratio of 103.48, a price-to-earnings-growth ratio of 2.41 and a beta of 1.19. The company’s 50-day moving average is $388.66 and its 200 day moving average is $349.22. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.29 and a current ratio of 1.86. Waters Corporation has a fifty-two week low of $282.77 and a fifty-two week high of $426.22.

Waters (NYSE:WAT – Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $3.05 EPS for the quarter, topping the consensus estimate of $3.01 by $0.04. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.62 billion. Waters had a net margin of 3.58% and a return on equity of 11.27%. The company’s revenue for the quarter was up 113.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. On average, equities research analysts forecast that Waters Corporation will post 14.56 earnings per share for the current year.

Insider Activity

In related news, Director Christopher A. Kuebler sold 3,626 shares of Waters stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total value of $1,442,930.44. Following the sale, the director owned 17,808 shares of the company’s stock, valued at approximately $7,086,515.52. The trade was a 16.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.31% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on WAT shares. TD Cowen raised shares of Waters from a “hold” rating to a “buy” rating and raised their price objective for the company from $408.00 to $475.00 in a research note on Wednesday, August 5th. UBS Group upped their target price on shares of Waters from $330.00 to $375.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Citigroup raised their price target on shares of Waters from $425.00 to $470.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Sanford C. Bernstein assumed coverage on Waters in a research note on Friday, June 26th. They set an “outperform” rating and a $435.00 price target for the company. Finally, Royal Bank Of Canada boosted their price objective on Waters from $435.00 to $475.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Three analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Waters presently has a consensus rating of “Moderate Buy” and an average price target of $424.35.

Check Out Our Latest Research Report on WAT

Waters Profile

(Free Report)

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.